16 PhD Positions in Münster (Germany): Imaging Cellular Processes and Disease CiM-IMPRS in Germany

The CiM-IMPRS graduate program, a collaboration between the International Max Planck Research School - Molecular Biomedicine and the Cells in Motion Interfaculty Centre at the University of Münster, offers 16 fully funded PhD positions in the life sciences. This interdisciplinary program is designed for early career scientists eager to explore cellular processes and disease mechanisms through advanced imaging techniques. Research projects span a wide range of topics, including cell and molecular biology, developmental biology, vascular biology, immunology, biophysics, neurobiology, in vivo imaging, and high-resolution optical imaging. The program encourages applicants interested in both basic cellular research and clinical translation, as well as those keen to develop new imaging-related methods and compounds.

Successful candidates will benefit from excellent scientific and transferable skills training, competitive work contracts or tax-free fellowships, and comprehensive support with administrative matters, accommodation, and visa applications. There are no tuition fees, and the program language is English, making it accessible to international students. The PhD projects are scheduled to begin in October 2026, with the possibility of earlier starts if desired.

Applicants must be highly qualified and motivated, holding a relevant degree in biology, biomedical sciences, or related fields. The program seeks students with a strong interest in interdisciplinary research and imaging technologies. While specific degree level, GPA, or language test requirements are not detailed, proficiency in English is necessary.

Applications can be submitted online from 2 March to 1 May 2026. For detailed information and to apply, visit the program website at https://www.uni-muenster.de/CiM-IMPRS. For further inquiries, contact the program at [email protected].

This is an outstanding opportunity to join a vibrant research community at the University of Münster and the Max Planck Institute for Molecular Biomedicine, working at the forefront of cellular imaging and disease research.